Johnson & Johnson
Search results
Change the Odds: Uniting to Improve Cancer Outcomes. At Pfizer, we believe that everyone should have the same opportunity to access the latest advances in cancer care, regardless of their background or where they live.
- Careers
Depending on the customs and laws of a specific country,...
- Products
In this section find an overview of our Pfizer Products and...
- Contact Us
Pfizer Inc. 66 Hudson Boulevard East New York, NY 10001-2192...
- Investors Overview
Forward-Looking Statements of Pfizer Inc. This transcript...
- Newsroom
Pfizer Inc. today introduced PfizerForAll, a user-friendly...
- Executives
Executives - Pfizer: One of the world's premier...
- Partners
Pfizer scientists are eager to work with world-class...
- Purpose
Charles Pfizer & Company was founded in Brooklyn in 1849 by...
- Careers
Homepage | Pfizer Philippines Inc. Media Science Contact Us. Breakthroughs that Change Patients' Lives. Company Timeline: A Legacy of Innovation So much has changed since we were founded in 1849. But not our commitment to finding innovations that help people. Explore the milestones along our journey. Learn More.
Pfizer Inc. (/ ˈfaɪzər / FY-zər) [3] is an American multinational pharmaceutical and biotechnology corporation headquartered at The Spiral in Manhattan, New York City. The company was established in 1849 in New York by two German entrepreneurs, Charles Pfizer (1824–1906) and his cousin Charles F. Erhart (1821–1891).
At Pfizer, we apply science and our global resources to bring therapies to people that extend and significantly improve their lives. We strive to set the standard for quality, safety, and value in the discovery, development, and manufacture of health care products.
Pfizer Philippines was officially established with 9 colleagues. Pfizer partnered with Metro Drug Corporation to import and distribute Pfizer products. Back then, Metro Drug had a sales force of only three people. Ludwig A. Armerding was Pfizer PH's first ever country manager. 1957
We're elevating our breakthroughs in a bold new way on Pfizer.com. Check out our new visualized product pipeline, where you'll be able to take a deep dive into our working innovations and see where each product is in development! Find out more.
Pfizer Inc. and BioNTech SE announced today they have begun an evaluation of the safety and immunogenicity of a third dose of the Pfizer-BioNTech COVID-19 vaccine (BNT162b2) to understand the effect of a booster on immunity against COVID-19 caused by the circulating and potential newly emerging SARS-CoV-2 variants.
